{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T21:25:27Z","timestamp":1746653127159,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00347-020-01099-1","type":"journal-article","created":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T11:03:08Z","timestamp":1586948588000},"page":"1080-1086","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neues zur Therapie der okul\u00e4ren Tuberkulose","Treatment of ocular tuberculosis\u2014an update"],"prefix":"10.1007","volume":"117","author":[{"given":"Larissa Christina","family":"Br\u00f6nnimann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Zimmerli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3973-5082","authenticated-orcid":false,"given":"Justus Gerhard","family":"Garweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"1099_CR1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/jamaophthalmol.2017.4485","volume":"135","author":"R Agrawal","year":"2017","unstructured":"Agrawal\u00a0R, Gunasekeran\u00a0DV, Grant\u00a0R, Agarwal\u00a0A, Kon\u00a0OM, Nguyen\u00a0QD, Pavesio\u00a0C, Gupta\u00a0V, Collaborative Ocular Tuberculosis Study (COTS)-1 Study Group (2017) Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1. JAMA Ophthalmol 135:1318\u20131327","journal-title":"JAMA Ophthalmol"},{"key":"1099_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bjid.2018.03.005","volume":"22","author":"SBV Oliveira","year":"2018","unstructured":"Oliveira\u00a0SBV, Passos \u00c2F, Hadad\u00a0DJ, Zbyszynski\u00a0L, de Almeida J\u00fanior\u00a0PS, Castellani\u00a0LGS, Dietze\u00a0R, Palaci\u00a0M (2018) The impact of ocular tuberculosis on vision after two months of intensive therapy. Braz J Infect Dis 22:159\u2013165","journal-title":"Braz J Infect Dis"},{"key":"1099_CR3","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.survophthal.2016.03.001","volume":"61","author":"AR Kee","year":"2016","unstructured":"Kee\u00a0AR, Gonzalez-Lopez\u00a0JJ, Al-Hity\u00a0A, Gupta\u00a0B, Lee\u00a0CS, Gunasekeran\u00a0DV, Jayabalan\u00a0N, Grant\u00a0R, Kon\u00a0OM, Gupta\u00a0V, Westcott\u00a0M, Pavesio\u00a0C, Agrawal\u00a0R (2016) Anti-tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol 61:628\u2013653","journal-title":"Surv Ophthalmol"},{"key":"1099_CR4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ophtha.2010.08.011","volume":"118","author":"KJ Wroblewski","year":"2011","unstructured":"Wroblewski\u00a0KJ, Hidayat\u00a0AA, Neafie\u00a0RC, Rao\u00a0NA, Zapor\u00a0M (2011) Ocular tuberculosis: a\u00a0clinicopathologic and molecular study. Ophthalmology 118:772\u2013777","journal-title":"Ophthalmology"},{"key":"1099_CR5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1869-5760-4-10","volume":"4","author":"PK Balne","year":"2014","unstructured":"Balne\u00a0PK, Modi\u00a0RR, Choudhury\u00a0N, Mohan\u00a0N, Barik\u00a0MR, Padhi\u00a0TR, Sharma\u00a0S, Panigrahi\u00a0SR, Basu\u00a0S (2014) Factors influencing polymerase chain reaction outcomes in patients with clinically suspected ocular tuberculosis. J\u00a0Ophthalmic Inflamm Infect 4:10. https:\/\/doi.org\/10.1186\/1869-5760-4-10","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1099_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12348-019-0183-x","volume":"9","author":"SK Ganesh","year":"2019","unstructured":"Ganesh\u00a0SK, Abraham\u00a0S, Sudharshan\u00a0S (2019) Paradoxical reactions in ocular tuberculosis. J\u00a0Ophthalmic Inflamm Infect 9:19. https:\/\/doi.org\/10.1186\/s12348-019-0183-x","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"1099_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bjophthalmol-2016-309531","volume":"101","author":"M Ang","year":"2017","unstructured":"Ang\u00a0M, Chee\u00a0SP (2017) Controversies in ocular tuberculosis. Br J Ophthalmol 101:6\u20139","journal-title":"Br J Ophthalmol"},{"key":"1099_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/09273948.2014.926936","volume":"23","author":"SM Lou","year":"2015","unstructured":"Lou\u00a0SM, Larkin\u00a0KL, Winthrop\u00a0K, Rosenbaum\u00a0JT, Uveitis Specialists Study Group (2015) Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists. Ocul Immunol Inflamm 23:25\u201331","journal-title":"Ocul Immunol Inflamm"},{"key":"1099_CR9","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/09273948.2014.994784","volume":"23","author":"SM Lou","year":"2015","unstructured":"Lou\u00a0SM, Montgomery\u00a0PA, Larkin\u00a0KL, Winthrop\u00a0K, Zierhut\u00a0M, Rosenbaum\u00a0JT, Uveitis Specialists Study Group (2015) Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective. Ocul Immunol Inflamm 23:32\u201339","journal-title":"Ocul Immunol Inflamm"},{"key":"1099_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.survophthal.2007.08.015","volume":"52","author":"V Gupta","year":"2007","unstructured":"Gupta\u00a0V, Gupta\u00a0A, Rao\u00a0NA (2007) Intraocular tuberculosis\u2014an update. Surv Ophthalmol 52:561\u2013587","journal-title":"Surv Ophthalmol"},{"key":"1099_CR11","doi-asserted-by":"publisher","first-page":"e8614","DOI":"10.1371\/journal.pone.0008614","volume":"5","author":"M Berney","year":"2010","unstructured":"Berney\u00a0M, Cook\u00a0GM (2010) Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia. Plos One 5:e8614. https:\/\/doi.org\/10.1371\/journal.pone.0008614","journal-title":"Plos One"},{"key":"1099_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-019-0748-9","author":"K Shirley","year":"2020","unstructured":"Shirley\u00a0K, Dowlut\u00a0S, Silvestri\u00a0J, Pavesio\u00a0C, Foot\u00a0B (2020) Presumed ocular tuberculosis in the United Kingdom: a\u00a0British Ophthalmological Surveillance Unit (BOSU) study. Eye. https:\/\/doi.org\/10.1038\/s41433-019-0748-9","journal-title":"Eye"},{"key":"1099_CR13","doi-asserted-by":"publisher","first-page":"1800591","DOI":"10.1183\/13993003.00591-2018","volume":"52","author":"CC Dobler","year":"2018","unstructured":"Dobler\u00a0CC, Fox\u00a0GJ, Douglas\u00a0P, Viney\u00a0KA, Khan\u00a0AF, Temesgen\u00a0Z, Marais\u00a0BJ (2018) Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives. Eur Respir\u00a0J 52:1800591. https:\/\/doi.org\/10.1183\/13993003.00591-2018","journal-title":"Eur Respir J"},{"key":"1099_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S2213-2600(18)30057-2","volume":"6","author":"K Floyd","year":"2018","unstructured":"Floyd\u00a0K, Glaziou\u00a0P, Zumla\u00a0A, Raviglione\u00a0M (2018) The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. Lancet Respir Med 6:299\u2013314","journal-title":"Lancet Respir Med"},{"key":"1099_CR15","doi-asserted-by":"publisher","first-page":"e0219706","DOI":"10.1371\/journal.pone.0219706","volume":"14","author":"D Couvin","year":"2019","unstructured":"Couvin\u00a0D, Reynaud\u00a0Y, Rastogi\u00a0N (2019) Two tales: worldwide distribution of Central Asian (CAS) versus ancestral East-African Indian (EAI) lineages of mycobacterium tuberculosis underlines a\u00a0remarkable cleavage for phylogeographical, epidemiological and demographical characteristics. PLoS ONE 14:e219706. https:\/\/doi.org\/10.1371\/journal.pone.0219706","journal-title":"PLoS ONE"},{"key":"1099_CR16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/eye.2012.1","volume":"26","author":"M Ang","year":"2012","unstructured":"Ang\u00a0M, Wong\u00a0W, Ngan\u00a0CC, Chee\u00a0SP (2012) Interferon-gamma release assay as a\u00a0diagnostic test for tuberculosis-associated uveitis. Eye 26:658\u2013665","journal-title":"Eye"},{"key":"1099_CR17","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3201\/eid2403.171633","volume":"24","author":"DT Nguyen","year":"2018","unstructured":"Nguyen\u00a0DT, Teeter\u00a0LD, Graves\u00a0J, Graviss\u00a0EA (2018) Characteristics associated with negative interferon\u2011\u03b3 release assay results in culture-confirmed tuberculosis patients, texas, USA, 2013\u20132015. Emerg Infect Dis 24:534\u2013540","journal-title":"Emerg Infect Dis"},{"key":"1099_CR18","doi-asserted-by":"publisher","first-page":"e18564","DOI":"10.1371\/journal.pone.0018564","volume":"6","author":"PP Singh","year":"2011","unstructured":"Singh\u00a0PP, LeMaire\u00a0C, Tan\u00a0JC, Zeng\u00a0E, Schorey\u00a0JS (2011) Exosomes released from M. tuberculosis infected cells can suppress IFN\u2011\u03b3 mediated activation of na\u00efve macrophages. Plos One 6:e18564. https:\/\/doi.org\/10.1371\/journal.pone.0018564","journal-title":"Plos One"},{"key":"1099_CR19","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.4049\/jimmunol.1600584","volume":"197","author":"L Moreira-Teixeira","year":"2016","unstructured":"Moreira-Teixeira\u00a0L, Sousa\u00a0J, McNab\u00a0FW, Torrado\u00a0E, Cardoso\u00a0F, Machado\u00a0H, Castro\u00a0F, Cardoso\u00a0V, Gaifem\u00a0J, Wu\u00a0X, Appelberg\u00a0R, Castro\u00a0AG, O\u2019Garra\u00a0A, Saraiva\u00a0M (2016) Type I IFN inhibits alternative macrophage activation during mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN\u2011\u03b3 signaling. J\u00a0Immunol 197:4714\u20134726","journal-title":"J Immunol"},{"key":"1099_CR20","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1111\/j.1755-3768.2012.02564.x","volume":"91","author":"V Lloren\u00e7","year":"2013","unstructured":"Lloren\u00e7\u00a0V, Gonz\u00e1lez-Martin\u00a0J, Keller\u00a0J, Rey\u00a0A, Pelegr\u00edn\u00a0L, Mesquida\u00a0M, Ad\u00e1n\u00a0A (2013) Indirect supportive evidence for diagnosis of tuberculosis-related uveitis: from the tuberculin skin test to the new interferon gamma release assays. Acta Ophthalmol 91:e99\u2013e107","journal-title":"Acta Ophthalmol"},{"key":"1099_CR21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1136\/bjophthalmol-2014-305229","volume":"98","author":"M Ang","year":"2014","unstructured":"Ang\u00a0M, Kiew\u00a0SY, Wong\u00a0WL, Chee\u00a0SP (2014) Discordance of two interferon\u2011\u03b3 release assays and tuberculin skin test in patients with uveitis. Br J Ophthalmol 98:1649\u20131653","journal-title":"Br J Ophthalmol"},{"key":"1099_CR22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/bjophthalmol-2012-302199","volume":"97","author":"M Ang","year":"2013","unstructured":"Ang\u00a0M, Wong\u00a0WL, Li\u00a0X, Chee\u00a0SP (2013) Interferon \u03b3 release assay for the diagnosis of uveitis associated with tuberculosis: a\u00a0Bayesian evaluation in the absence of a\u00a0gold standard. Br J Ophthalmol 97:1062\u20131067","journal-title":"Br J Ophthalmol"},{"key":"1099_CR23","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jamaophthalmol.2017.3514","volume":"135","author":"RN Van Gelder","year":"2017","unstructured":"Van Gelder\u00a0RN (2017) Uveitis-the tortured tale of the tubercle. JAMA Ophthalmol 135:1328\u20131329","journal-title":"JAMA Ophthalmol"},{"key":"1099_CR24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.rmr.2010.10.034","volume":"28","author":"J Perriot","year":"2011","unstructured":"Perriot\u00a0J, Chambonnet\u00a0E, Eschalier\u00a0A (2011) Managing the adverse events of antitubercular agents. Rev Mal Respir 28:542\u2013555","journal-title":"Rev Mal Respir"},{"key":"1099_CR25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/IAE.0b013e3182215b5e","volume":"32","author":"M Zhang","year":"2012","unstructured":"Zhang\u00a0M, Zhang\u00a0J, Liu\u00a0Y (2012) Clinical presentations and therapeutic effect of presumed choroidal tuberculosis. Retina 32:805\u2013813","journal-title":"Retina"},{"key":"1099_CR26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0161-6420(02)00973-9","volume":"109","author":"Y Morimura","year":"2002","unstructured":"Morimura\u00a0Y, Okada\u00a0AA, Kawahara\u00a0S, Miyamoto\u00a0Y, Kawai\u00a0S, Hirakata\u00a0A, Hida\u00a0T (2002) Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology 109:851\u2013857","journal-title":"Ophthalmology"},{"key":"1099_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0039-2016","author":"CA Haley","year":"2017","unstructured":"Haley\u00a0CA (2017) Treatment of latent tuberculosis infection. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.TNMI7-0039-2016","journal-title":"Microbiol Spectr"},{"key":"1099_CR28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ajo.2018.03.032","volume":"190","author":"O Tomkins-Netzer","year":"2018","unstructured":"Tomkins-Netzer\u00a0O, Leong\u00a0BCS, Zhang\u00a0X, Lightman\u00a0S, McCluskey\u00a0PJ, Sydney-London Latent Ocular TB Study Group (2018) Effect of antituberculous therapy on uveitis associated with latent tuberculosis. Am J Ophthalmol 190:164\u2013170","journal-title":"Am J Ophthalmol"},{"key":"1099_CR29","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ajo.2008.06.011","volume":"146","author":"R Bansal","year":"2008","unstructured":"Bansal\u00a0R, Gupta\u00a0A, Gupta\u00a0V, Dogra\u00a0MR, Bambery\u00a0P, Arora\u00a0SK (2008) Role of anti-tubercular therapy in uveitis with latent\/manifest tuberculosis. Am J Ophthalmol 146:772\u2013779","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1099_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09273948.2019.1698752","volume":"2020","author":"B Schrijver","year":"2020","unstructured":"Schrijver\u00a0B, Hardjosantoso\u00a0H, Ten Berge\u00a0JCEM, Schreurs\u00a0MWJ, Van Hagen\u00a0PM, Brooimans\u00a0RA, Rothova\u00a0A, Dik\u00a0WA (2020) No evidence for circulating retina specific autoreactive T\u2011cells in latent tuberculosis-associated uveitis and sarcoid uveitis. Ocul Immunol Inflamm 2020(8):1\u20137. https:\/\/doi.org\/10.1080\/09273948.2019.1698752","journal-title":"Ocul Immunol Inflamm"},{"key":"1099_CR31","first-page":"498","volume":"24","author":"K Babu","year":"2016","unstructured":"Babu\u00a0K, Bhat\u00a0SS, Philips\u00a0M, Subbakrishna\u00a0DK (2016) Review of results of quantiFERON TB gold test in presumed ocular tuberculosis in a\u00a0south Indian patient population. Ocul Immunol Inflamm 24:498\u2013502","journal-title":"Ocul Immunol Inflamm"},{"key":"1099_CR32","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/S0161-6420(03)00619-5","volume":"110","author":"V Gupta","year":"2003","unstructured":"Gupta\u00a0V, Gupta\u00a0A, Arora\u00a0S, Bambery\u00a0P, Dogra\u00a0MR, Agarwal\u00a0A (2003) Presumed tubercular serpiginouslike choroiditis: clinical presentations and management. Ophthalmology 110:1744\u20131749","journal-title":"Ophthalmology"},{"key":"1099_CR33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4103\/ijo.IJO_822_18","volume":"67","author":"P Dutta Majumder","year":"2019","unstructured":"Dutta Majumder\u00a0P, Biswas\u00a0J, Gupta\u00a0A (2019) Enigma of serpiginous choroiditis. Indian J Ophthalmol 67:325\u2013333","journal-title":"Indian J Ophthalmol"},{"key":"1099_CR34","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s10792-017-0739-4","volume":"38","author":"DR Brunner","year":"2018","unstructured":"Brunner\u00a0DR, Zweifel\u00a0SA, Barthelmes\u00a0D, Meier\u00a0F, B\u00f6ni\u00a0C (2018) Review of people with retinal vasculitis and positive QuantiFERON(\u00ae)-TB Gold test in an area nonendemic for tuberculosis. Int Ophthalmol 38:2389\u20132395","journal-title":"Int Ophthalmol"},{"key":"1099_CR35","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/bjo.83.8.994","volume":"83","author":"J Biswas","year":"1999","unstructured":"Biswas\u00a0J, Therese\u00a0L, Madhavan\u00a0HN (1999) Use of polymerase chain reaction in detection of Mykobakterium tuberculosis complex DNA from vitreous sample of Eales\u2019 disease. Br J Ophthalmol 83:994","journal-title":"Br J Ophthalmol"},{"key":"1099_CR36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jfo.2016.03.001","volume":"39","author":"MH Errera","year":"2016","unstructured":"Errera\u00a0MH, Pratas\u00a0A, Goldschmidt\u00a0P, Sedira\u00a0N, Sahel\u00a0JA, Benesty\u00a0J (2016) Eales\u2019 disease. J\u00a0Fr Ophtalmol 39:474\u2013482","journal-title":"J Fr Ophtalmol"},{"key":"1099_CR37","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/ICU.0b013e328358ba01","volume":"23","author":"S Yeh","year":"2012","unstructured":"Yeh\u00a0S, Sen\u00a0HN, Colyer\u00a0M, Zapor\u00a0M, Wroblewski\u00a0K (2012) Update on ocular tuberculosis. Curr Opin Ophthalmol 23:551\u2013556","journal-title":"Curr Opin Ophthalmol"},{"key":"1099_CR38","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1093\/cid\/ciw376","volume":"63","author":"P Nahid","year":"2016","unstructured":"Nahid\u00a0P, Dorman\u00a0SE, Alipanah\u00a0N, Barry\u00a0PM, Brozek\u00a0JL, Cattamanchi\u00a0A, Chaisson\u00a0LH, Chaisson\u00a0RE, Daley\u00a0CL, Grzemska\u00a0M, Higashi\u00a0JM, Ho\u00a0CS, Hopewell\u00a0PC, Keshavjee\u00a0SA, Lienhardt\u00a0C, Menzies\u00a0R, Merrifield\u00a0C, Narita\u00a0M, O\u2019Brien\u00a0R, Peloquin\u00a0CA, Raftery\u00a0A, Saukkonen\u00a0J, Schaaf\u00a0HS, Sotgiu\u00a0G, Starke\u00a0JR, Migliori\u00a0GB, Vernon\u00a0A (2016) Official American thoracic society\/centers for disease control and prevention\/infectious diseases society of america clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 63:e147\u2013e195. https:\/\/doi.org\/10.1093\/cid\/ciw376","journal-title":"Clin Infect Dis"},{"key":"1099_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.01.008","author":"R Agrawal","year":"2020","unstructured":"Agrawal\u00a0R, Testi\u00a0I, Mahajan\u00a0S, Yuen\u00a0YS, Agarwal\u00a0A, Kon\u00a0OM, Barisani-Asenbauer\u00a0T, Kempen\u00a0JH, Gupta\u00a0A, Jabs\u00a0DA, Smith\u00a0JR, Nguyen\u00a0QD, Pavesio\u00a0C, Gupta\u00a0V, Collaborative Ocular Tuberculosis Study Consensus Group (2020) Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis-report 1: guidelines for initiating antitubercular therapy in tubercular choroiditis. Ophthalmology. https:\/\/doi.org\/10.1016\/j.ophtha.2020.01.008","journal-title":"Ophthalmology"},{"key":"1099_CR40","first-page":"31","volume":"23","author":"L Figueira","year":"2017","unstructured":"Figueira\u00a0L, Fonseca\u00a0S, Ladeira\u00a0I, Duarte\u00a0R (2017) Ocular tuberculosis: position paper on diagnosis and treatment management. Rev Port Pneumol 23:31\u201338","journal-title":"Rev Port Pneumol"},{"key":"1099_CR41","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.ophtha.2009.05.021","volume":"116","author":"A Garip","year":"2009","unstructured":"Garip\u00a0A, Diedrichs-M\u00f6hring\u00a0M, Thurau\u00a0SR, Deeg\u00a0CA, Wildner\u00a0G (2009) Uveitis in a\u00a0patient treated with Bacille-Calmette-Gu\u00e9rin: possible antigenic mimicry of mycobacterial and retinal antigens. Ophthalmology 116:2457\u20132462.e2","journal-title":"Ophthalmology"},{"key":"1099_CR42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/eye.2013.5","volume":"27","author":"S Basu","year":"2013","unstructured":"Basu\u00a0S, Nayak\u00a0S, Padhi\u00a0TR, Das\u00a0T (2013) Progressive ocular inflammation following anti-tubercular therapy for presumed ocular tuberculosis in a\u00a0high-endemic setting. Eye 27:657\u2013662","journal-title":"Eye"},{"key":"1099_CR43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4103\/ijo.IJO_184_17","volume":"65","author":"SK Ganesh","year":"2017","unstructured":"Ganesh\u00a0SK, Ali\u00a0BS (2017) Paradoxical worsening of a\u00a0case of TB subretinal abscess with serpiginous-like choroiditis following the initiation of antitubercular therapy. Indian J Ophthalmol 65:761\u2013764","journal-title":"Indian J Ophthalmol"},{"key":"1099_CR44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/09273948.2014.943350","volume":"23","author":"T Yilmaz","year":"2015","unstructured":"Yilmaz\u00a0T, Selcuk\u00a0E, Polat\u00a0N, Mutlu\u00a0K (2015) Choroidal tuberculoma showing paradoxical worsening in a\u00a0patient with miliary TB. Ocul Immunol Inflamm 23:97\u201399","journal-title":"Ocul Immunol Inflamm"},{"key":"1099_CR45","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/eye.2010.110","volume":"24","author":"S Basu","year":"2010","unstructured":"Basu\u00a0S, Das\u00a0T (2010) Pitfalls in the management of TB-associated uveitis. Eye 24:1681\u20131684","journal-title":"Eye"},{"key":"1099_CR46","first-page":"144","volume":"21","author":"AT Castro","year":"2015","unstructured":"Castro\u00a0AT, Mendes\u00a0M, Freitas\u00a0S, Roxo\u00a0PC (2015) Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a\u00a0period of 10 years. Rev Port Pneumol 21:144\u2013150","journal-title":"Rev Port Pneumol"},{"key":"1099_CR47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.5588\/ijtld.11.0766","volume":"17","author":"N Ezer","year":"2013","unstructured":"Ezer\u00a0N, Benedetti\u00a0A, Darvish-Zargar\u00a0M, Menzies\u00a0D (2013) Incidence of ethambutol-related visual impairment during treatment of active tuberculosis. Int J Tuberc Lung Dis 17:447\u2013455","journal-title":"Int J Tuberc Lung Dis"},{"key":"1099_CR48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/0970-2113.148428","volume":"32","author":"P Garg","year":"2015","unstructured":"Garg\u00a0P, Garg\u00a0R, Prasad\u00a0R, Mishra\u00a0AK (2015) A prospective study of ocular toxicity in patients receiving ethambutol as a\u00a0part of directly observed treatment strategy therapy. Lung India 32:16\u201319","journal-title":"Lung India"},{"key":"1099_CR49","first-page":"438","volume":"3","author":"SB Kokkada","year":"2005","unstructured":"Kokkada\u00a0SB, Barthakur\u00a0R, Natarajan\u00a0M, Palaian\u00a0S, Chhetri\u00a0AK, Mishra\u00a0P (2005) Ocular side effects of antitubercular drugs\u2014a\u00a0focus on prevention, early detection and management. Kathmandu Univ Med J 3:438\u2013441","journal-title":"Kathmandu Univ. Med. J."},{"key":"1099_CR50","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1136\/bjo.2008.148502","volume":"93","author":"V Menon","year":"2009","unstructured":"Menon\u00a0V, Jain\u00a0D, Saxena\u00a0R, Sood\u00a0R (2009) Prospective evaluation of visual function for early detection of ethambutol toxicity. Br J Ophthalmol 93:1251\u20131254","journal-title":"Br J Ophthalmol"},{"key":"1099_CR51","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/jop.2011.0095","volume":"28","author":"H Kandel","year":"2012","unstructured":"Kandel\u00a0H, Adhikari\u00a0P, Shrestha\u00a0GS, Ruokonen\u00a0EL, Shah\u00a0DN (2012) Visual function in patients on ethambutol therapy for tuberculosis. J\u00a0Ocul Pharmacol Ther 28:174\u2013178","journal-title":"J Ocul Pharmacol Ther"},{"key":"1099_CR52","doi-asserted-by":"publisher","first-page":"e0204655","DOI":"10.1371\/journal.pone.0204655","volume":"13","author":"BM Pavan Taffner","year":"2018","unstructured":"Pavan Taffner\u00a0BM, Mattos\u00a0FB, Cunha\u00a0MCD, Saraiva\u00a0FP (2018) The use of optical coherence tomography for the detection of ocular toxicity by ethambutol. PLoS ONE 13:e204655. https:\/\/doi.org\/10.1371\/journal.pone.0204655","journal-title":"PLoS ONE"},{"key":"1099_CR53","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/15569527.2015.1079784","volume":"35","author":"KL Kim","year":"2016","unstructured":"Kim\u00a0KL, Park\u00a0SP (2016) Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level. Cutan Ocul Toxicol 35:228\u2013232","journal-title":"Cutan Ocul Toxicol"},{"key":"1099_CR54","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.2174\/1381612820666140901215544","volume":"20","author":"S Goutelle","year":"2014","unstructured":"Goutelle\u00a0S, Bourguignon\u00a0L, Maire\u00a0P, Jelliffe\u00a0RW, Neely\u00a0MN (2014) The case for using higher doses of first line anti-tuberculosis drugs to optimize efficacy. Curr Pharm Des 20:6191\u20136206","journal-title":"Curr Pharm Des"},{"key":"1099_CR55","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/jop.2011.0095","volume":"28","author":"SK Ganesh","year":"2012","unstructured":"Ganesh\u00a0SK, Kandel\u00a0H, Adhikari\u00a0P, Shrestha\u00a0GS, Ruokonen\u00a0EL, Shah\u00a0DN (2012) Visual function in patients on ethambutol therapy for tuberculosis. J\u00a0Ocul Pharmacol Ther 28:174\u2013178","journal-title":"J Ocul Pharmacol Ther"},{"key":"1099_CR56","first-page":"230","volume":"35","author":"JL Goyal","year":"2003","unstructured":"Goyal\u00a0JL, De Sarmi, Singh\u00a0NP, Bhatia\u00a0A (2003) Evaluation of visual functions in patients on ethambutol therapy for tuberculosis: a\u00a0prospective study. J\u00a0Commun Dis 35:230\u2013243","journal-title":"J Commun Dis"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-020-01099-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T08:12:29Z","timestamp":1618474349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-020-01099-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,15]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1099"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01099-1","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"type":"print","value":"0941-293X"},{"type":"electronic","value":"1433-0423"}],"subject":[],"published":{"date-parts":[[2020,4,15]]},"assertion":[{"value":"15 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.G.\u00a0Garweg \u00fcbt bzw. hat eine Beraterfunktion ausge\u00fcbt f\u00fcr verschiedene pharmazeutische Unternehmen (Alcon, Allergan Bayer, Chengdu-Khanghong, Novartis) und nimmt an zahlreichen Industrie-gesponsorten internationalen Studien teil. Dies hatte keinen Einfluss auf die vorliegende Arbeit, die nicht durch externe Mittel unterst\u00fctzt wurde.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}